Key statistics dashboard for BillionToOne, Inc. (BLLN). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection.
Stock Data
| Price | $109.06 |
| Market Cap | $5.0B |
| Enterprise Value | $4.61B |
| Beta | -2.36 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 158.04 |
| Price / Book | 9.43 |
| P/S | 12.62 |
| EV/EBITDA | 91.78 |
| EV/Sales | 11.60 |
| EV/FCF | 139.01 |
| P/FCF | 151.21 |
| Earnings Yield | 0.66% |
| FCF Yield | 0.66% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 71.27% |
| EBIT Margin | 9.55% |
| EBITDA Margin | 12.64% |
| Operating Margin | 10.90% |
| Net Margin | 8.43% |
| Return on Equity | 7.87% |
| Return on Assets | 4.59% |
| Return on Invested Capital | 6.33% |
| Return on Capital Employed | 6.42% |
Financial Health
| Current Ratio | 11.69 |
| Quick Ratio | 11.31 |
| Cash Ratio | 9.85 |
| Debt / Equity | 0.27 |
| Debt / Assets | 19.72% |
| Net Debt / EBITDA | -8.05 |
| Interest Coverage | 1,056.15 |
Per-Share Data
| Revenue per share | 8.56 |
| Book Value per share | 11.57 |
| Cash per share | 11.82 |
| FCF per share | 0.71 |
| Tangible Book Value per share | 11.57 |
| Dividend per share | 0.00 |
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of BLLN: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks